Showing results (2091-2100 of 2,127) with videos related to

Sort By:
Pageof 213
Biorxiv : the Preprint Server for Biology|March 24, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian Windsor, et al.
Cell|November 10, 2020
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody ProductionYuezhou Chen, Adam Zuiani, Stephanie Fischinger, et al.
Cell Host & Microbe|November 19, 2024
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in miceJames Brett Case, Shilpa Sanapala, Carly Dillen, et al.
European Journal of Medical Research|August 26, 2021
Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reactionNorman-Philipp Hoff, Noemi F Freise, Albrecht G Schmidt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parametersM Linch, G Goh, C Hiley, et al.
Immunity|August 20, 2022
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responsesJeroen M J Tas, Ja-Hyun Koo, Ying-Cing Lin, et al.
NPJ Vaccines|February 14, 2023
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in miceEtsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, et al.
The Journal of Infectious Diseases|October 31, 2022
SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the OutcomeRaquel A Binder, Gavin F Fujimori, Catherine S Forconi, et al.
Nature Communications|March 28, 2023
Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2Brian C Sanders, Suman Pokhrel, Audrey D Labbe, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacyEric A Voight, Arthur R Gomtsyan, Jerome F Daanen, et al.
Pageof 213